tranexamic acid has been researched along with Hypopigmentation in 2 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Hypopigmentation: A condition caused by a deficiency or a loss of melanin pigmentation in the epidermis, also known as hypomelanosis. Hypopigmentation can be localized or generalized, and may result from genetic defects, trauma, inflammation, or infections.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Litaiem, N | 1 |
| Daadaa, N | 1 |
| Karray, M | 1 |
| Chamli, A | 1 |
| Zeglaoui, F | 1 |
| Merideth, MA | 1 |
| Introne, WJ | 1 |
| Wang, JA | 1 |
| O'Brien, KJ | 1 |
| Huizing, M | 1 |
| Gochuico, BR | 1 |
2 other studies available for tranexamic acid and Hypopigmentation
| Article | Year |
|---|---|
Hypopigmentation as a side effect of melasma treatment with tranexamic acid intradermal microinjections.
Topics: Antifibrinolytic Agents; Humans; Hypopigmentation; Melanosis; Microinjections; Tranexamic Acid | 2020 |
Genetic variants associated with Hermansky-Pudlak syndrome.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Blood Platelets; Carrier Proteins; Contusions; Deamino A | 2020 |